# Embassy Bancorp, Inc.: financial statements, quarterly

EMYB · OTC · CIK 1449794 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/emyb.md) · [Financials](/companies/emyb/financials.md) · [Filings](/companies/emyb/filings.md) · [Insiders](/companies/emyb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/emyb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [5,113](/filings/0001449794-23-000032.md) | [5,987 d](/filings/0001449794-24-000003.md) | [6,378](/filings/0001449794-24-000010.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [667](/filings/0001449794-24-000023.md) | [613 d](/filings/0001449794-25-000002.md) | [487](/filings/0001449794-25-000009.md) | [506](/filings/0001449794-25-000020.md) | [531](/filings/0001449794-25-000035.md) | [545 d](/filings/0001449794-26-000003.md) | [621](/filings/0001449794-26-000009.md) | [691](/filings/0001449794-26-000028.md) | [811](/filings/0001449794-25-000035.md) | [776 d](/filings/0001449794-26-000003.md) | [839](/filings/0001449794-26-000009.md) | [869](/filings/0001449794-26-000028.md) |
| Net income | $k | [3,002](/filings/0001449794-24-000023.md) | [2,820 d](/filings/0001449794-25-000002.md) | [2,536](/filings/0001449794-25-000035.md) | [2,492](/filings/0001449794-25-000035.md) | [2,714](/filings/0001449794-25-000035.md) | [2,698 d](/filings/0001449794-26-000003.md) | [2,887](/filings/0001449794-26-000028.md) | [3,437](/filings/0001449794-26-000028.md) | [3,793](/filings/0001449794-25-000035.md) | [3,580 d](/filings/0001449794-26-000003.md) | [3,739](/filings/0001449794-26-000028.md) | [4,123](/filings/0001449794-26-000028.md) |
| Diluted EPS | $ per share | [0.39](/filings/0001449794-24-000023.md) | not reported | [0.33](/filings/0001449794-25-000009.md) | [0.33](/filings/0001449794-25-000020.md) | [0.36](/filings/0001449794-25-000035.md) | not reported | [0.38](/filings/0001449794-26-000009.md) | [0.45](/filings/0001449794-26-000028.md) | [0.50](/filings/0001449794-25-000035.md) | not reported | [0.50](/filings/0001449794-26-000009.md) | [0.56](/filings/0001449794-26-000028.md) |
| Basic EPS | $ per share | [0.39](/filings/0001449794-24-000023.md) | not reported | [0.33](/filings/0001449794-25-000009.md) | [0.33](/filings/0001449794-25-000020.md) | [0.36](/filings/0001449794-25-000035.md) | not reported | [0.38](/filings/0001449794-26-000009.md) | [0.45](/filings/0001449794-26-000028.md) | [0.50](/filings/0001449794-25-000035.md) | not reported | [0.50](/filings/0001449794-26-000009.md) | [0.56](/filings/0001449794-26-000028.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,676](/filings/0001449794-23-000032.md) | [1,656](/filings/0001449794-25-000002.md) | [1,653](/filings/0001449794-24-000010.md) | [1,717](/filings/0001449794-24-000020.md) | [1,715](/filings/0001449794-24-000023.md) | [1,704](/filings/0001449794-26-000003.md) | [1,754](/filings/0001449794-25-000009.md) | [1,759](/filings/0001449794-25-000020.md) | [1,778](/filings/0001449794-25-000035.md) | [1,801](/filings/0001449794-26-000028.md) | [1,842](/filings/0001449794-26-000009.md) | [1,859](/filings/0001449794-26-000028.md) |
| Total liabilities | $m | [1,590](/filings/0001449794-23-000032.md) | [1,551](/filings/0001449794-25-000002.md) | [1,549](/filings/0001449794-24-000010.md) | [1,614](/filings/0001449794-24-000020.md) | [1,601](/filings/0001449794-24-000023.md) | [1,598](/filings/0001449794-26-000003.md) | [1,642](/filings/0001449794-25-000009.md) | [1,645](/filings/0001449794-25-000020.md) | [1,656](/filings/0001449794-25-000035.md) | [1,673](/filings/0001449794-26-000028.md) | [1,717](/filings/0001449794-26-000009.md) | [1,731](/filings/0001449794-26-000028.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [85.6](/filings/0001449794-24-000023.md) | [106](/filings/0001449794-26-000003.md) | [104](/filings/0001449794-25-000035.md) | [103](/filings/0001449794-25-000035.md) | [114](/filings/0001449794-25-000035.md) | [106](/filings/0001449794-26-000028.md) | [112](/filings/0001449794-26-000028.md) | [114](/filings/0001449794-26-000028.md) | [122](/filings/0001449794-25-000035.md) | [128](/filings/0001449794-26-000028.md) | [125](/filings/0001449794-26-000028.md) | [128](/filings/0001449794-26-000028.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [5,659 d](/filings/0001449794-24-000023.md) | [2,760 d](/filings/0001449794-25-000002.md) | [1,806](/filings/0001449794-25-000009.md) | [303 d](/filings/0001449794-25-000020.md) | [5,669 d](/filings/0001449794-25-000035.md) | [2,166 d](/filings/0001449794-26-000003.md) | [2,684](/filings/0001449794-26-000009.md) | [2,275 d](/filings/0001449794-26-000028.md) | [3,990 d](/filings/0001449794-25-000035.md) | [3,884 d](/filings/0001449794-26-000003.md) | [4,831](/filings/0001449794-26-000009.md) | [3,181 d](/filings/0001449794-26-000028.md) |
| Capital expenditure | $k | [177 d](/filings/0001449794-24-000023.md) | [207 d](/filings/0001449794-25-000002.md) | [274](/filings/0001449794-25-000009.md) | [56.0 d](/filings/0001449794-25-000020.md) | [157 d](/filings/0001449794-25-000035.md) | [252 d](/filings/0001449794-26-000003.md) | [78.0](/filings/0001449794-26-000009.md) | [305 d](/filings/0001449794-26-000028.md) | [121 d](/filings/0001449794-25-000035.md) | [128 d](/filings/0001449794-26-000003.md) | [175](/filings/0001449794-26-000009.md) | [243 d](/filings/0001449794-26-000028.md) |
| Dividends paid | $k | not reported | [0.0 d](/filings/0001449794-25-000002.md) | not reported | not reported | not reported | [0.0 d](/filings/0001449794-26-000003.md) | not reported | not reported | not reported | [0.0 d](/filings/0001449794-26-000003.md) | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,573](/filings/0001449794-23-000032.md) | [7,592](/filings/0001449794-24-000010.md) | [7,602](/filings/0001449794-24-000020.md) | [7,603](/filings/0001449794-24-000023.md) | [7,603](/filings/0001449794-25-000009.md) | [7,617](/filings/0001449794-25-000020.md) | [7,618](/filings/0001449794-25-000035.md) | [7,637](/filings/0001449794-26-000009.md) | [7,644](/filings/0001449794-26-000028.md) | [7,645](/filings/0001449794-25-000035.md) | [7,536](/filings/0001449794-26-000009.md) | [7,412](/filings/0001449794-26-000028.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,405,604 at 2026-08-07, from the cover of the [10-Q filed 2026-08-13](/filings/0001449794-26-000028.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.